ReviewFrontiers in molecular biosciences2023
Biosafety and biohazard considerations of HSV-1-based oncolytic viral immunotherapy.
Elizabeth Robilotti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it